Clinical Trials Sponsored by Allergan

Total 4263 results

Allergan Medical

Completed

Safety and Effectiveness of Juvéderm® Volbella With Lidocaine Versus Restylane-L® for Lip Volume Enhancement

Lip Volume Enhancement

United Kingdom, France
Allergan Medical

Completed

Juvederm Ultra With Lidocaine Compared With Restylane for the Correction of Nasolabial Folds

Nasolabial Folds

Canada
Allergan Medical

Completed

Safety and Effectiveness of Juvéderm® Ultra Lip Injectable Gel for Lip Enhancement

Lip Enhancement

United Kingdom
Allergan Medical

Completed

Postmarket Study of JUVÉDERM VOLBELLA™ With Lidocaine in the Lips

Lip Augmentation

Germany
Allergan Medical

Completed

Adjunct Study of Natrelle(TM) Cohesive Round Silicone-Filled Breast Implants

Breast Reconstruction

United States
Allergan Medical

Withdrawn

EasyBand GOAL Trial

Morbid Obesity

United States, Canada
Allergan Medical

Completed

The Volumizing Effect of Juvéderm VOLUMA® in the Mid-Face

Age-related Volume Deficit in the Mid-face

Belgium, Netherlands, Germany, United Kingdom
Allergy Therapeutics
Bencard Allergie GmbH

Active, not recruiting

Tyrosine Allergoid Paediatric and Adult Study

Allergic Conjunctivitis | Allergic Asthma | Allergic Rhinitis Due to Pollen

Germany
Allergan Medical

Completed

Safety and Effectiveness of Style 410 Silicone-Filled Breast Implant Study

Breast Augmentation | Breast Reconstruction | Revision of Augmentation or Reconstruction

United States
Allergan Medical

Completed

Safety and Effectiveness of Natrelle(TM) Cohesive Round Silicone-Filled Breast Implants

Breast Augmentation | Breast Reconstruction | Revision of Augmentation or Reconstruction

United States
Allergan Medical

Completed

Safety and Effectiveness of JUVÉDERM™ Injectable Gel With Lidocaine

Nasolabial Folds

United States
Allergan Medical

Completed

European Union (EU) Post-Market Study on Easyband®

Morbid Obesity

Belgium, Netherlands, United Kingdom, Italy
Allergan

Recruiting

18 Month Prospective Efficacy and Safety Study of Bimatoprost Intracameral Implant (DURYSTA) (ARGOS)

Ocular Hypertension | Open-angle Glaucoma

United States
Allergan

Completed

A Study to Assess Adverse Events and Change in Disease Activity of Intramuscular AGN-151586 Injection in Toxin-Naïve Adult Participants With Glabellar Lines

Glabellar Lines

United States, Canada
Allergan

Completed

CoolSculpting® Elite for Non-Invasive Fat Reduction

Non-invasive Fat Reduction

United States, France, Singapore, Sweden, Germany
Allergan

Completed

A Study To Assess the Safety and Effects of OnabotulinumtoxinA (BOTOX) Intramuscular Injection in Adult Participants With Platysma Prominence

Platysma Prominence

United States, Belgium, Canada, Germany, United Kingdom
Allergan

Completed

A Study Evaluating JUVÉDERM VOLUMA® XC Injectable Gel for Correction of Temple Hollowing in Adult Participants Over 22 Years Old

Temple Hollowing

United States, Puerto Rico
Allergan

Enrolling by invitation

A Study Evaluating Oral Eluxadoline Administered to Pediatric Participants With Irritable Bowel Syndrome With Diarrhea (IBS-D)

Irritable Bowel Syndrome

United States
Allergan

Completed

Safety and Effectiveness of the XEN45 Glaucoma Treatment System in Patients With Angle Closure Glaucoma

Glaucoma | Angle-Closure

Australia, Canada, Korea, Republic of, Singapore, Taiwan, United Kingdom
Allergan

Completed

A Study to Assess Safety and Efficacy in Participants Age 40 to 55 With Presbyopia (Old Eye) Who Receive AGN-190584 in Both Eyes Twice Daily (Virgo)

Presbyopia

United States
Allergan

Completed

Study of the Safety and Effectiveness of JUVÉDERM VOLUX™ XC Injectable Gel for Restoring Jawline Definition

Jawline Definition

United States
Allergan

Completed

Long Term Prospective Uncontrolled Study Of Earfold™ For The Treatment Of Prominent Ears (FOLD)

Prominent Ears

United Kingdom
Allergan

Completed

A Study to Evaluate Androderm®'s Effect on Blood Pressure in Adult Hypogonodal Male Participants

Hypogonadism

United States
Allergan

Completed

Efficacy and Safety of a New Artificial Tear Formulation Compared With Systane Ultra Multidose in Participants With Dry Eye Disease

Dry Eye Disease (DED)

United States
Allergan

Completed

A Study of Armour® Thyroid Compared to Synthetic T4 (Levothyroxine) in Previously Hypothyroid Participants

Hypothyroidism | Thyroid Disease | Euthyroid | Thyroid Gland | Thyroid Hormones

United States
Allergan

Completed

A Comparison of Bimatoprost SR to Selective Laser Trabeculoplasty in Patients With Open-Angle Glaucoma or Ocular Hypertension

Glaucoma | Open-Angle Ocular Hypertension

Spain, United States, Singapore, Australia, Denmark, France, Poland, Russian Federation, Thailand
Allergan

Completed

A Phase 3 Efficacy Study of Pilocarpine HCl Ophthalmic Solution (AGN-190584) in Participants With Presbyopia (GEMINI 2)

Presbyopia

United States
Allergan

Completed

Efficacy Study of Pilocarpine HCl Ophthalmic Solution (AGN-190584) in Participants With Presbyopia (GEMINI 1)

Presbyopia

United States
Allergan

Terminated

A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 03

Diabetes Mellitus | Gastroparesis

United States, Canada, Australia, Russian Federation, India, Thailand, Korea, Republic of, Singapore, Mexico, Israel, Poland, Belgium, Bulgaria, Malaysia, Philippines, Ukraine, South Africa, Austria, Brazil, United Kingdom, Arge... and more
Allergan

Completed

Intradermal (ID) BOTOX in the Treatment of Facial Fine Lines

Facial Fine Lines

United States
Allergan

Terminated

Goblet Cell Degranulation Produced by Intranasal Tear Neurostimulator (ITN) in Dry Eye Disease

Dry Eye Syndromes

United States
Allergan

Completed

A Study to Evaluate the Effectiveness of Juvéderm® VOLIFT™ With Lidocaine for Lip Augmentation (LIPS)

Lip Augmentation

Portugal, United Kingdom
Allergan

Completed

Efficacy and Safety of Bimatoprost Sustained-Release (SR) in Patients With Open-Angle Glaucoma or Ocular Hypertension

Ocular Hypertension | Glaucoma, Open-Angle

United States, Singapore, Italy, United Kingdom, Egypt, Korea, Republic of, Argentina, Canada, Colombia, Czechia, Germany, Malaysia, New Zealand, South Africa, Turkey
Allergan

Completed

12-Week Placebo-controlled Study of Atogepant for the Preventive Treatment of Migraine in Participants With Episodic Migraine

Episodic Migraine

United States
Allergan

Completed

Eluxadoline Bile Acid Malabsorption (BAM) Study

Irritable Bowel Syndrome With Diarrhea

United States
Allergan

Completed

Safety, Tolerability and Drug- Drug Interaction Study of Ubrogepant With Erenumab or Galcanezumab in Participants With Migraine

Migraine

United States
Allergan

Terminated

Clinical Study to Evaluate Tear Characteristics Following Acute TrueTear™ Use

Dry Eye Syndromes

United Kingdom
Allergan

Completed

A Safety, Efficacy and Pharmacokinetic Study of AGN-199201 and AGN-190584 in Patients With Presbyopia

Presbyopia

United States
Allergan

Completed

Safety and Efficacy of TrueTear™ for the Treatment of Meibomian Gland Disease

Dry Eye Syndromes | Meibomian Glands

United States
Allergan

Completed

Safety and Efficacy of Abicipar Pegol in Participants With Neovascular Age-related Macular Degeneration

Macular Degeneration

United States, Japan, United Kingdom, Italy, Taiwan, Australia, Canada, Hungary, Poland, Russian Federation, Netherlands, Brazil, Denmark, Peru, South Africa, Turkey
Allergan

Completed

A Safety and Efficacy Study of Abicipar Pegol in Participants With Neovascular Age-related Macular Degeneration (CEDAR)

Macular Degeneration

Spain, United States, Korea, Republic of, Israel, Singapore, Argentina, Germany, France, Czechia, Austria, Philippines, Switzerland, Chile, Colombia, Hong Kong, Latvia, New Zealand
Allergan

Terminated

Safety and Effectiveness of NATRELLE® 410 Highly Cohesive, Anatomically Shaped, Silicone-filled X-Style and L-Style Breast Implants

Breast Augmentation | Breast Reconstruction | Breast Implant Revision

United States
Allergan

Terminated

NATRELLE® 410 X-Style and L-Style Breast Implants Continued Access Study

Breast Augmentation | Breast Reconstruction | Breast Implant Revision

United States
Allergan

Completed

A Long-Term Extension Study of OnabotulinumtoxinA (BOTOX®) for Urinary Incontinence Due to Neurogenic Detrusor Overactivity

Urinary Incontinence

United States, Belgium, Czechia, Canada, France, Italy, Poland, Turkey
Allergan

Completed

Study of OnabotulinumtoxinA (BOTOX®) for Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Pediatric Patients

Urinary Incontinence

United States, Belgium, Canada, Poland, Italy, France, Czechia, Turkey
Allergan

Completed

A Long-Term Safety and Efficacy Study AGN-19920 in Patients With Persistent Erythema Associated With Rosacea

Erythema | Rosacea

United States
Allergan

Completed

Study of Inter- and Intra-rater Reliability of the Clinician Erythema Assessment Scale

Erythema | Rosacea

United States
Allergan

Completed

Dynamic Optical Coherence Tomography(D-OCT) Aging Study: A Preliminary Evaluation of Structural Differences Between Young and Aged Skin, Cellulite and Atrophic Acne Scars in Female Caucasian Subjects With Fitzpatrick Skin Types I-III Utilizing Non-invasive in Vivo D-OCT.

Skin Care

United States
Allergan

Completed

Evaluation of Eflornithine on Facial and Forearm Skin

Hirsutism
Allergan

Completed

Safety and Effectiveness of JUVÉDERM® VOLBELLA® With Lidocaine for Lip Enhancement in Chinese Adults

Lip Enhancement

China

3

Subscribe